Friday, July 19, 2019
Home Launches

Launches

Latest
Progress in compound library development for epitranscriptomic drug discovery

Roivant launches new biopharma focussed on Asian market

Dominic Cuthbert -
Catalent acquires gene therapy specialist in $1.2bn deal

New biotech targeting muscle diseases launches with $50m

Dominic Cuthbert -
Xofluza well tolerated in children with flu, Phase III data shows

New global flu strategy launched by WHO

Dominic Cuthbert -
Safety assessment solution launched enabling first-in-human clinical trials

Safety assessment solution launched enabling first-in-human clinical trials

Dominic Cuthbert -
Biogen rolls out Cleo app for UK multiple sclerosis patients

Biogen rolls out Cleo app for UK multiple sclerosis patients

Dominic Cuthbert -
Forxiga approved in Europe for type-1 diabetes

Lilly launching lower-priced insulin

Dominic Cuthbert -
First-in-human trial of universal flu vaccine candidate begins

UK launch for Pelmeg following EU approval

Dominic Cuthbert -
Maze Therapeutics launched to translate genetic insight into new medicines

Maze Therapeutics launched to translate genetic insight into new medicines

Dominic Cuthbert -
Catalent Biologics boosts gene therapy footprint

UK launches new National Genomic Healthcare Strategy

Dominic Cuthbert -
Novartis & Black Life Sciences launch new biopharma company

Novartis & Black Life Sciences launch new biopharma company

Dominic Cuthbert -
1234Page 1 of 4

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

© 2019 Pharma Business International - https://www.pbiforum.net/mag